Safety and immunogenicity of rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine against SARS-CoV-2 in healthy adolescents: an open-label, non-randomized, multicenter, phase 1/2, dose-escalation study. Amir I Tukhvatulin , Inna V Dolzhikova , Alina S Dzharullaeva , Daria M Grousova , Anna V Kovyrshina , Olga V Zubkova , Ilya D Zorkov , Anna A Iliukhina , Artem Y Shelkov , Alina S Erokhova , Olga Popova , Tatiana A Ozharovskaia , Denis I Zrelkin , Fatima M Izhaeva , Dmitry V Shcheblyakov , Ilias B Esmagambetov , Elisaveta A Tokarskaya , Natalia A Nikitenko , Nadezhda L Lubenets , Elizaveta A Khadorich , Vladimir A Gushchin , Svetlana N Borzakova , Anna V Vlasova , Ismail M Osmanov , Valerii V Gorev , Boris S Naroditsky , Denis Y Logunov , Alexander L Gintsburg Frontiers in immunology（2023）
摘要
ClinicalTrials.gov, NCT04954092, LP-007632.
更多 查看译文
关键词
Sputnik M, Sputnik V, Gam-COVID-Vac, SARS-CoV-2, COVID-19
AI 理解论文
溯源树
样例
